August 8, 2018 5:42pm
The rebounds of yesterday’s Q2 releases is one key to sentiment!
As well as pipeline progress and cash positions that facilitates runways
Pre-open indications: 9 hits and 2 miss
Closing numbers, Q2/18 earning’s reporting: Adverum Biotechnologies (ADVM +$0.15), Regenxbio (RGNX -$0.25) Sangamo Therapeutics (SGMO -$0.25), uniQure (QURE -$0.53) and Verastem (VSTM +$0.10)
Financing initiated: REGENXBIO (RGNX) proposes a $175 M offering
Consider these end-of-day results as Thursday’s primer. Every investor should want to know WHY, WHAT, HOW and WHEN to roll in, out or just “hang-in”?
A “buck” a day keeps your portfolio in the play - should have a subscriber … you would be reading this now!
My motto, “Never leave an investor uninformed”!
Members only. Please login.